The Earlier the Better? Assessing Early Entry Agreements in the Pharmaceutical Sector

被引：0

作者：

Carbonnel, Alexandre ^{[1
]}

Lee, Connie ^{[1
]}

机构：

[1] NERA Econ Consulting, Paris, France

来源：

JOURNAL OF EUROPEAN COMPETITION LAW & PRACTICE | 2023年 / 14卷 / 03期

关键词：

D O I：

10.1093/jeclap/lpad003

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

[No abstract available]

引用

页码：177 / 183

页数：7

共 50 条

[41] Assessing the impact of non-pharmaceutical interventions on disease infection in the public health sector: a hybrid simulation approach
Shbool, Mohammad A.
Al-Bazi, Ammar
Zureigat, Laith
Mahafzah, Azmi M.
International Journal of Simulation and Process Modelling, 2024, 21 (02) : 130 - 146
[42] Opportunities and Threats of the Legally Facilitated Performance-Based Managed Entry Agreements in Slovakia: The Early-Adoption Perspective
Hospodkova, Petra
Gilikova, Klara
Bartak, Miroslav
Marusakova, Elena
Tichopad, Ales
HEALTHCARE, 2023, 11 (08)
[43] Assessing the Impact of Field-of-Use Restrictions in Patent Licensing Agreements: The Ethical Pharmaceutical Industry in the United States, 1950-1962
Villar, Mar Cebrian
Garcia, Santiago Lopez
ENTERPRISE & SOCIETY, 2017, 18 (02) : 282 - 323
[44] Managed Entry Agreements for Pharmaceutical Products in Middle East and North African Countries: Payer and Manufacturer Experience and Outlook (vol 16, pg 33, 2018)
Maskineh, C.
VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 148 - 148
[45] Very early enzyme replacement therapy is "The earlier; the better" for infantile Pompe disease: Experience of nationwide newborn screening program in Taiwan
Yang, Chia Feng
MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S127 - S127
[46] How to shorten the market entry innovation in a highly regulated market. The case of Early access programs in the pharmaceutical industry
Bastone, Anna
Schiavone, Francesco
Carli, Maria Rosaria
Juarez-Varon, David
INTERNATIONAL ENTREPRENEURSHIP AND MANAGEMENT JOURNAL, 2023, 19 (04) : 1561 - 1581
[47] How to shorten the market entry innovation in a highly regulated market. The case of Early access programs in the pharmaceutical industry
Anna Bastone
Francesco Schiavone
Maria Rosaria Carli
David Juárez-Varón
International Entrepreneurship and Management Journal, 2023, 19 : 1561 - 1581
[48] The sooner, the better: The economic impact of non-pharmaceutical interventions during the early stage of the COVID-19 pandemic
Demirguc-Kunt, Asli
Lokshin, Michael
Torre, Ivan
ECONOMICS OF TRANSITION AND INSTITUTIONAL CHANGE, 2021, 29 (04) : 551 - 573
[49] The Rural Clinical School Tracking Project: More IS better - Confirming factors that influence early career entry into the rural medical workforce
Eley, Diann
Baker, Peter
Chater, Bruce
MEDICAL TEACHER, 2009, 31 (10) : E454 - E459
[50] Diagnosing cancer earlier: reviewing the evidence for improving cancer survivalThe National Awareness and Early Diagnosis Initiative in England: assessing the evidence 5 years on
S C Hiom
British Journal of Cancer, 2015, 112 (Suppl 1) : S1 - S5

← 1 2 3 4 5 →